For localized information and support, would you like to switch to your country-specific website for {0}?
Get our latest insights
Join our community and stay up to date with the latest laboratory innovations and insights.
For localized information and support, would you like to switch to your country-specific website for {0}?
In healthcare, more technology doesn’t automatically mean more value. The difference often comes down to who you choose to partner with, and how. Download this practical executive guide to learn how value-based procurement helps you cut through vendor complexity, reduce workflow burden, and deliver real impact for your organization.
Get your complimentary copy of “Choosing partners, not solutions” delivered straight to your inbox.
We’ve sent the guide to your inbox.
Traditionally, healthcare has been delivered and paid for based largely on a “fee-for-service” arrangement, with healthcare providers receiving compensation for services rendered or procedures conducted. Yet, over the last decades, this system that incentivizes providers on the volume and quantity of those services provided, has become unsustainable.
Costs are rising at an alarming rate.1,2 The increase in healthcare spend may be attributed to various factors including better healthcare options in emerging markets,3 the use of newer and more expensive technologies,4 a growing elderly population5 and an increase in complex chronic conditions.6
Yet the enormous investments being made are not translating into fundamental improvements in health, and we seem to be at a point of diminishing returns. This is borne out in the statistics, which show that greater healthcare spending does not seem to correlate with improved care or health outcomes.7,8
In 2006, a book entitled “Redefining Health Care: Creating Value-Based Competition on Results” by Michael Porter and Elizabeth Teisberg addressed this fundamental question vexing the healthcare sector – why, in spite of intense competition and high spending, was the US healthcare system failing?
According to their analysis, improving patient value was not the primary goal of those acting in the healthcare system, who were instead focused on reducing costs – specifically their own, short-term costs.9
The proposed alternative: What if, instead of billing merely for time and resources related to excessive non-productive treatment, HCPs were compensated for making sure that the patient’s condition was improved or resolved? This is what we call value-based healthcare, or VBHC. It means:
VBHC represents a fundamental shift in how healthcare is delivered. It is a movement away from asking patients, “What is a matter with you?” to “What matters to you”.10 Rather, it is a patient-centered approach to delivery focused on improving the health outcomes that matter most to patients across the entire cycle of care, while concurrently optimizing the use of healthcare resources and cost to society.11
The “value” in VBHC is about focusing on improving patient health outcomes throughout the entire patient journey:
While there are good examples of VBHC being implemented in locations around the world, full implementation in the real-world setting remains challenging. Some of the obstacles include increased financial risk and possible loss of revenue, ill-defined outcomes measures, improved IT system requirements, and policy frameworks that support VBHC.
In their research, Michael Porter and Elizabeth Teisberg developed a strategic, six-step framework for the implementation of VBHC called “the Value Agenda.”12 Essentially, this framework recommends that:
Defining the proper payment scheme is one of the obstacles to, and a fundamental principle of successful implementation of, a VBHC model. In fact, there are several possible reimbursement models that move away from the traditional fee-for-service models towards more outcome-based models aimed to improve care processes, enhance patient experience, and create achievable benchmarks for improved outcomes.13 These include:
Bundled payments seem poised to remain a commonly used payment method for VBHC14 because they directly incentivize achieving better patient outcomes at a lower cost.
In vitro diagnostics (IVDs) already play a key role in today’s healthcare system, influencing over 66% of clinical decision-making, while accounting for only about 2% of total healthcare spending.15 They are a low-risk and relatively low-cost way to generate critical information to inform diagnosis, treatment, and, eventually, outcomes. Yet the discussion of the “value” of diagnostic tests often revolves around their accuracy and their sensitivity. In addition, tests are currently not reimbursed with patient value in mind, but rather on a fee-for-service basis, with little incentive to change the status quo.
Within the context of VBHC, however, they need to be evaluated on the testing strategy used, and on the quality and accuracy of decision-making by healthcare providers as a result of using the test,16 including the ultimate impact on the health of patients.
What kind of impact can implementing a VBHC model make? How can VBHC help address rising costs that do not consistently equate to better quality care? And how do all healthcare stakeholders – patients, providers, payers – need to work together to make this shift happen? To help answer this and many more questions, please download our ebook Value-based healthcare: Patient-centric outcomes at the foundation of care.
This ebook aims to answer the following:
Join our community and stay up to date with the latest laboratory innovations and insights.
Drive healthcare innovation with access to critical perspectives and exclusive events.
Healthcare Transformers delivers insights on the emerging trends shaping modern healthcare: digital health, patient experience, value-based care, and data security. Partnering with global experts and innovators, we tackle the industry's toughest challenges and explore actionable solutions.
Subscribe to our newsletter today to get invaluable perspectives delivered straight to your inbox.
References